An Explorative Study of Oral Microemulsion-based Formulation for the Delivery of Cabazitaxel and Piperine
Abstract
Cabazitaxel is the newest version of taxanes and is a promising drug for managing various cancers. Like other taxanes, this drug also poses a challenge of solubility and permeability, resulting in a poor oral bioavailability. The present study explores a scalable and economic nanoformulation in the microemulsion form for the oral delivery of cabazitaxel. The developed system substantially improved the drug’s anticancer activity on the breast cancer cell lines and in vivo cancer models. Piperine was also loaded in the microemulsion and it was observed that the incorporation of piperine resulted in an oral formulation with substantially higher oral bioavailability of CBZ vis-à-vis plain drug as well as the microemulsion. The findings infer that biocompatible microemulsions can enhance the oral bioavailability and anticancer activity of CBZ, which was further improved after incorporating piperine.
Keywords:
Taxanes, Oral Delivery, Bioavailability, MTT, Controlled Release, NanoemulsionDOI
https://doi.org/10.25004/IJPSDR.2022.140307References
Paller CJ, Antonarakis ES. Cabazitaxel: A novel second-line treatment for metastatic castration-resistant prostate cancer. Drug Des Devel Ther 2011:117–24.
Abidi A. Cabazitaxel: A novel taxane for metastatic castration-resistant prostate cancer-current implications and future prospects. J Pharmacol Pharmacother 2013;4:230–7.
Suzuki K, Matsubara N, Kazama H et al. S afety a nd e fficacy o f cabazitaxel in 660 patients with metastatic castration-resistant prostate cancer in real-world settings: Results of a Japanese post-marketing surveillance study. Jpn J Clin Oncol 2019;49:1157–63.
Maloney SM, Hoover CA, Morejon-Lasso L V. et al. Mechanisms of taxane resistance. Cancers (Basel) 2020;12:1–57.
Kaushik L, Srivastava S, Panjeta A et al. Exploration of docetaxel palmitate and its solid lipid nanoparticles as a novel option for alleviating the rising concern of multidrug resistance. Int J Pharm 2020;578, DOI: 10.1016/j.ijpharm.2020.119088.
Kumar M, Sharma G, Misra C et al. N-desmethyl tamoxifen and quercetin-loaded multiwalled CNTs: A synergistic approach to overcome MDR in cancer cells. Mater Sci Eng C 2018;89:274–82.
Katare O, Raza K, Singh B et al. Novel drug delivery systems in topical treatment of psoriasis: Rigors and vigors. Indian J Dermatol Venereol Leprol 2010;76:612–21.
Raza K. Nanotechnology-based Drug Delivery Products: Need, Design, Pharmacokinetics and Regulations. Curr Pharm Des 2019;24:5085–5085.
Ghosh P, Murthy R. Microemulsions: A Potential Drug Delivery System. Curr Drug Deliv 2006;3:167–80.
Raza K, Negi P, Takyar S et al. Novel dithranol phospholipid mic roemulsion for topical appl icat ion: development , characterizat ion and percutaneous absorpt ion studies. J Microencapsul 2011;28:190–9.
Singh A, Thotakura N, Singh B et al. Delivery of Docetaxel to Brain Employing Piperine-Tagged PLGA-Aspartic Acid Polymeric Micelles: Improved Cytotoxic and Pharmacokinetic Profiles. AAPS PharmSciTech 2019;20:220:1–10.
Sharma G, Dhankar G, Thakur K et al. Benzyl Benzoate-Loaded Microemulsion for Topical Applications: Enhanced Dermatokinetic Profile and Better Delivery Promises. AAPS PharmSciTech 2015:1–11.
Thakur K, Sharma G, Katare OP. Topical Drug Delivery of anti-infectives employing Lipid-Based Nanocarriers: Dermatokinetics as an important tool. Curr Pharm Des 2019;25, DOI: 10.2174/1381 612825666190118155843.
Raza K, Negi P, Takyar S et al. Novel dithranol phospholipid mic roemulsion for topical appl icat ion: Development , characterizat ion and percutaneous absorpt ion studies. J Microencapsul 2011;28:190–9.
Oser BL, Ford RA. Recent Progress in the Consideration of Flavoring Ingredients Under the Food Additives Amendment 11. GRAS Substances., 1978.
Moghimipour E, Salimi A, Karami M et al. Preparation and characterization of dexamethasone microemulsion based on pseudoternary phase diagram. Jundishapur J Nat Pharm Prod 2013;8:105–12.
Rozana R, Yulizar Y, Saefumillah A et al. Synthesis, characterization and in vitro release study of efavirenz-loaded chitosan nanoparticle. AIP Conf Proc 2020;2242:229–36.
Thakkar VT, Shah PA, Soni TG et al. Goodness-of-fit model-dependent approach for release kinetics of levofloxacin hemihydrates floating tablet. Dissolution Technol 2009;16:35–9.
Raza K, Thotakura N, Kumar P et al. C60-fullerenes for delivery of docetaxel to breast cancer cells: A promising approach for enhanced efficacy and better pharmacokinetic profile. Int J Pharm 2015;495:551–9.
Raza K, Kumar P, Kumar N et al. Pharmacokinetics and biodistribution of the nanoparticles. Advances in Nanomedicine for the Delivery of Therapeutic Nucleic Acids. Elsevier Inc., 2017, 166–86.
Ahad A, Al-Saleh AA, Akhtar N et al. Transdermal delivery of antidiabetic drugs: formulation and delivery strategies. Drug Discov Today 2015;20:1217–27.
Kommineni N, Mahira S, Domb AJ et al. Cabazitaxel-loaded nanocarriers for cancer therapy with reduced side effects. Pharmaceutics 2019;11:1–22.
Lambers H, Piessens S, Bloem A et al. Natural skin surface pH is on average below 5, which is beneficial for its resident flora. Int J Cosmet Sci 2006;28:359–70.
Ren T, Wang Q, Xu Y et al. Enhanced oral absorption and anticancer efficacy o f c abazitaxel b y o vercoming i ntestinal m ucus a nd epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles. J Control Release 2018;269:423–38.
Bhardwaj RK, Glaeser H, Becquemont L et al. Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. J Pharmacol Exp Ther 2002;302:645–50.
Beg S, Raza K, Kumar R et al. Improved intestinal lymphatic drug targeting via phospholipid complex-loaded nanolipospheres of rosuvastatin calcium. RSC Adv 2016;6:8173–87.
Published
Abstract Display: 621 
PDF Downloads: 436 
